PAVmed Inc (NAS:PAVM)

$ 1.79 -0.09 (-4.79%) Market Cap: 16.88 Mil Enterprise Value: 49.81 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q1 2024 PAVmed Inc Earnings Call Transcript
4 days ago

$2.22 (+15.63%)

Earnings
Q4 2023 PAVmed Inc Earnings Call Transcript
Mar 27, 2024

$2.73 (+32.52%)

Earnings
Q3 2023 PAVmed Inc Earnings Call Transcript
Nov 15, 2023

$2.82 (+0.14%)

Earnings
Q2 2023 PAVmed Inc Earnings Call Transcript
Aug 16, 2023

$3.23 (-17.31%)

Earnings
PAVmed Inc Annual Shareholders Meeting Transcript
Jun 21, 2023
Q1 2023 PAVmed Inc Earnings Call Transcript
May 17, 2023

$5.87 (-11.39%)

Earnings
PAVmed Inc Extraordinary Shareholders Meeting Transcript
Mar 31, 2023
Q4 2022 PAVmed Inc Earnings Call Transcript
Mar 15, 2023

$5.49 (-6.68%)

Earnings
PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call Transcript
Jan 17, 2023
Q3 2022 PAVmed Inc Earnings Call Transcript
Nov 15, 2022

$12.28 (-9.24%)

Earnings
Q2 2022 PAVmed Inc Earnings Call Transcript
Aug 16, 2022

$25.27 (-12.78%)

Earnings
PAVmed Inc Annual Shareholders Meeting Transcript
Jun 21, 2022
Q1 2022 PAVmed Inc Earnings Call Transcript
May 12, 2022

$13.78 (-4.42%)

Earnings
Q4 2021 PAVmed Inc Earnings Call Transcript
Mar 29, 2022

$20.55 (+4.55%)

Earnings
Q3 2021 PAVmed Inc Earnings Call Transcript
Nov 16, 2021

$62.8 (+0.41%)

Earnings
PAVmed Inc Host Digital Health Virtual Investor Event Transcript
Oct 26, 2021
PAVmed Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 30, 2021
Q2 2021 PAVmed Inc Earnings Call Transcript
Aug 12, 2021

$93.43 (+5.32%)

Earnings
Q1 2021 PAVmed Inc Earnings Call Transcript
May 17, 2021

$50.42 (-1.99%)

Earnings
PAVmed Inc Extraordinary Shareholders Meeting Transcript
Mar 04, 2021
Q4 2020 PAVmed Inc Earnings Call Transcript
Feb 22, 2021

$70.84 (+21.44%)

Earnings
Q3 2020 PAVmed Inc Earnings Call Transcript
Nov 17, 2020

$22.72 (-1.66%)

Earnings
Q2 2020 PAVmed Inc Earnings Call Transcript
Aug 18, 2020

$26.68 (-1.42%)

Earnings
PAVmed Inc Annual Shareholders Meeting Transcript
Jul 24, 2020
Q1 2020 PAVmed Inc Earnings Call Transcript
May 21, 2020

$33.82 (+1.53%)

Earnings
Q4 2019 PAVmed Inc Earnings Call Transcript
Apr 09, 2020

$24.38 (-1.55%)

Earnings
Q3 2019 PAVmed Inc Earnings Call Transcript
Nov 21, 2019

$11.43 (-5.18%)

Earnings
Q2 2019 PAVmed Inc Earnings Call Transcript
Sep 05, 2019

$12.18 (-2.66%)

Earnings
Q1 2019 PAVmed Inc Earnings Call Transcript
May 21, 2019

$13.21 (-5.48%)

Earnings

Q2 2023 PAVmed Inc Earnings Call Transcript

Aug 16, 2023 / 12:30PM GMT

Release Date Price: $3.23 (-17.31%)

Transcript 10-Q

Operator

Good day, and welcome to the PAVmed Second Quarter 2023 Business Update Conference Call. (Operator Instructions) Please note, today's event is being recorded.

I would now like to turn the conference over to Michael Parks, Vice President of Investor Relations. Please go ahead, sir.

Michael Parks

PAVmed Inc. - VP of IR

Thank you, Rocco. Good morning, everyone, and thank you for participating in today's second quarter 2023 business update call. The press release announcing our business update for the company and financial results for the 3 and 6 months ended June 30, 2023, is available on the PAVmed website.

Please take a moment to read the disclaimer about forward-looking statements. The business update press release and this conference call include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made.

Factors that could cause actual results to differ are described in the disclaimer and in our

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.